Literature DB >> 26455669

Marijuana use is associated with worse outcomes in symptom severity and violent behavior in patients with posttraumatic stress disorder.

Samuel T Wilkinson1, Elina Stefanovics, Robert A Rosenheck.   

Abstract

OBJECTIVE: An increasing number of states have approved posttraumatic stress disorder (PTSD) as a qualifying condition for medical marijuana, although little evidence exists evaluating the effect of marijuana use in PTSD. We examined the association between marijuana use and PTSD symptom severity in a longitudinal, observational study.
METHOD: From 1992 to 2011, veterans with DSM-III/-IV PTSD (N = 2,276) were admitted to specialized Veterans Affairs treatment programs, with assessments conducted at intake and 4 months after discharge. Subjects were classified into 4 groups according to marijuana use: those with no use at admission or after discharge ("never-users"), those who used at admission but not after discharge ("stoppers"), those who used at admission and after discharge ("continuing users"), and those using after discharge but not at admission ("starters"). Analyses of variance compared baseline characteristics and identified relevant covariates. Analyses of covariance then compared groups on follow-up measures of PTSD symptoms, drug and alcohol use, violent behavior, and employment.
RESULTS: After we adjusted for relevant baseline covariates, marijuana use was significantly associated with worse outcomes in PTSD symptom severity (P < .01), violent behavior (P < .01), and measures of alcohol and drug use (P < .01) when compared with stoppers and never-users. At follow-up, stoppers and never-users had the lowest levels of PTSD symptoms (P < .0001), and starters had the highest levels of violent behavior (P < .0001). After adjusting for covariates and using never-users as a reference, starting marijuana use had an effect size on PTSD symptoms of +0.34 (Cohen d = change/SD), and stopping marijuana use had an effect size of -0.18.
CONCLUSIONS: In this observational study, initiating marijuana use after treatment was associated with worse PTSD symptoms, more violent behavior, and alcohol use. Marijuana may actually worsen PTSD symptoms or nullify the benefits of specialized, intensive treatment. Cessation or prevention of use may be an important goal of treatment. © Copyright 2015 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2015        PMID: 26455669      PMCID: PMC6258013          DOI: 10.4088/JCP.14m09475

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  37 in total

1.  Employment outcomes and PTSD symptom severity.

Authors:  Mark W Smith; Paula P Schnurr; Robert A Rosenheck
Journal:  Ment Health Serv Res       Date:  2005-06

2.  Substance use and community violence: a test of the relation at the daily level.

Authors:  Edward P Mulvey; Candice Odgers; Jennifer Skeem; William Gardner; Carol Schubert; Charles Lidz
Journal:  J Consult Clin Psychol       Date:  2006-08

3.  Cannabis use and violent behaviour: a psychiatric patients cohort study in Southern Italy.

Authors:  Felice Carabellese; Chiara Candelli; Domenico Martinelli; Donatella La Tegola; Roberto Catanesi
Journal:  Riv Psichiatr       Date:  2013 Jan-Feb       Impact factor: 1.911

4.  PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program.

Authors:  George R Greer; Charles S Grob; Adam L Halberstadt
Journal:  J Psychoactive Drugs       Date:  2014 Jan-Mar

5.  Comparison of treatment outcomes for veterans with posttraumatic stress disorder with and without comorbid substance use/dependence.

Authors:  Alan Fontana; Robert Rosenheck; Rani Desai
Journal:  J Psychiatr Res       Date:  2012-06-27       Impact factor: 4.791

6.  Posttraumatic stress, difficulties in emotion regulation, and coping-oriented marijuana use.

Authors:  Marcel O Bonn-Miller; Anka A Vujanovic; Matthew Tyler Boden; James J Gross
Journal:  Cogn Behav Ther       Date:  2011

7.  Analysis of violent behavior in Vietnam combat veteran psychiatric inpatients with posttraumatic stress disorder.

Authors:  M McFall; A Fontana; M Raskind; R Rosenheck
Journal:  J Trauma Stress       Date:  1999-07

8.  Violent behavior as related to use of marijuana and other drugs.

Authors:  A S Friedman; K Glassman; B A Terras
Journal:  J Addict Dis       Date:  2001

Review 9.  Functional associations among trauma, PTSD, and substance-related disorders.

Authors:  S H Stewart; R O Pihl; P J Conrod; M Dongier
Journal:  Addict Behav       Date:  1998 Nov-Dec       Impact factor: 3.913

10.  The time course and significance of cannabis withdrawal.

Authors:  Alan J Budney; Brent A Moore; Ryan G Vandrey; John R Hughes
Journal:  J Abnorm Psychol       Date:  2003-08
View more
  30 in total

1.  Treatment outcomes for veterans with PTSD and substance use: Impact of specific substances and achievement of abstinence.

Authors:  Ajay Manhapra; Elina Stefanovics; Robert Rosenheck
Journal:  Drug Alcohol Depend       Date:  2015-09-25       Impact factor: 4.492

Review 2.  WHY NOT POT?: A Review of the Brain-based Risks of Cannabis.

Authors:  Kai MacDonald; Katherine Pappas
Journal:  Innov Clin Neurosci       Date:  2016-04-01

3.  [On the legalization debate of non-medical cannabis consumption : Position paper of the German Association for Psychiatry, Psychotherapy and Psychosomatics].

Authors:  U Havemann-Reinecke; E Hoch; U W Preuss; F Kiefer; A Batra; G Gerlinger; I Hauth
Journal:  Nervenarzt       Date:  2017-03       Impact factor: 1.214

4.  DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults.

Authors:  Ofir Livne; Dvora Shmulewitz; Shaul Lev-Ran; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2018-10-22       Impact factor: 4.492

5.  The Problem with the Current High Potency THC Marijuana from the Perspective of an Addiction Psychiatrist.

Authors:  Elizabeth Stuyt
Journal:  Mo Med       Date:  2018 Nov-Dec

Review 6.  Cannabis regulatory science: risk-benefit considerations for mental disorders.

Authors:  Jacob T Borodovsky; Alan J Budney
Journal:  Int Rev Psychiatry       Date:  2018-05-29

7.  Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential.

Authors:  Sabrina L Botsford; Sharon Yang; Tony P George
Journal:  Am J Addict       Date:  2019-10-02

8.  Cannabis industry and medical cannabis clinics need regulation.

Authors:  Meldon Kahan; Anita Srivastava; Sarah Clarke
Journal:  Can Fam Physician       Date:  2019-12       Impact factor: 3.275

9. 

Authors:  Meldon Kahan; Anita Srivastava; Sarah Clarke
Journal:  Can Fam Physician       Date:  2019-12       Impact factor: 3.275

10.  Neural mechanisms of sensitivity to peer information in young adult cannabis users.

Authors:  Jodi M Gilman; Randi M Schuster; Max T Curran; Vanessa Calderon; Andre van der Kouwe; A Eden Evins
Journal:  Cogn Affect Behav Neurosci       Date:  2016-08       Impact factor: 3.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.